Products in Development
DVC manages a variety of vaccine and therapeutic development programs to protect against potential biological and chemical threat agents and infectious diseases.
DVC is more than vaccines. We are experts dedicated to understanding each client's individual situation. The case studies listed below highlight some of our accomplishments in product development.
Biological Defense: Plague Vaccine
This case study details DVC's work for the Department of Defense Joint Vaccine Acquisition Program (JVAP) to develop a new plague vaccine candidate.
Regulatory Affairs: Fast Track Vaccine Programs
This case study details DVC's experience with the U.S. Food and Drug Administration's Fast Track Program.
Chemical Defense: BioScavenger
This case study details DVC's work for the Department of Defense Medical Identification and Treatment Systems (MITS) Joint Product Management Office to develop a new treatment for chemical nerve agents.
Biological Defense: Botulinum Neurotoxin Vaccine
This case study details the work DVC is doing with the U.S. Department of Defense Chemical Biological Medical Systems-Joint Vaccine Acquisition Program (CBMS-JVAP) to develop a vaccine to protect against botulinum neurotoxin serotypes A and B.